Clinical Biomanufacturing

Flexibility For Every Project

As an innovation-driven CDMO, Scorpius is committed to collaboration, efficiency and effectiveness. Our flexibly designed cGMP biomanufacturing facility embodies all three qualities.

We combine a modular approach to construction with the utilization of single-use systems to maximize our capabilities while minimizing the risk of cross-contamination in our multi-product facility. Scorpius delivers the support clients need across the full product lifecycle, from analytical method and process development through viral vector, mammalian and microbial manufacturing.

Platform Technologies

Mammalian Cell Culture

Microbial Fermentation

Cell Therapy Development

Protein-based Therapeutics

CLINICAL BIOMANUFACTURING CAPABILITIES

Scorpius' pre-clinical and clinical-scale contract biologics manufacturing facility is located in the heart of America in San Antonio, Texas.

Scorpius' biomanufacturing facilities provide world-class capabilities utilizing single-use, disposable technology for cost-effective production. Single-use systems reduce the risk of contamination and/or cross-contamination, allow for quick changeover between batches and reduce or eliminate the need for cleaning validation studies.

Scorpion_Composit_ColorCorrected_compressed

Clinical-scale biomanufacturing facility at the VelocityTX Innovation Center in San Antonio, Texas

2,000 sq. ft.

Available space in Scorpius' cGMP-compliant process development lab

2,000 SQ. FT.

Size of the analytical testing lab

8,600 SQ. FT.

Total available space in two independent cGMP-compliant biomanufacturing areas

Our commitment to American biomanufacturing means that all of our facilities use American-manufactured equipment and consumables, including the Pall Allegro™ STR single-use family of stirred tank bioreactors, which deliver consistent and scalable cell culture and microbial fermentation performance.

Capabilities include:

Mammalian cell culture manufacturing using bioreactors with capacities up to 500 L
Microbial fermentation in reactors with capacities up to 200 L
Cell harvest through bioprocess-scale centrifugation, continuous flow centrifugation, kSep 400 and microfiltration
Downstream processing including ultrafiltration/diafiltration, column chromatography, and sterile filtration

FACILITY DESIGN FEATURES

In addition to 8,600 total square feet of cGMP-compliant cleanroom biomanufacturing space, a 2,000 square-foot process development lab, and a 2,000 square-foot analytical testing lab, the facility also offers office, meeting, warehouse and mechanical space. Controlled, classified cleanroom space is segregated into two independent biologic manufacturing areas, located in two separate buildings on the VelocityTX campus.